No House member has disclosed a CVSA trade since 2025.
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 30, 2026 | Malafronte Michael WDirector | Stock Gift at price 0.00 per share. | 2.5K | — |
| Aug 26, 2026 | Gangadharan ManjunathOfficer | Sale at price 137.18 per share. | 1.8K | $247.20K |
| Aug 20, 2026 | Beard Stephen W.Chief Executive Officer | Stock Award(Grant) at price 132.35 per share. | 129.1K | $17.08M |
| Aug 20, 2026 | Beck Douglas GGeneral Counsel | Stock Award(Grant) at price 132.35 per share. | 10.3K | $1.36M |
| Aug 20, 2026 | Phelan, Robert JohnChief Financial Officer | Stock Award(Grant) at price 132.35 per share. | 17.1K | $2.27M |
| Aug 20, 2026 | Gangadharan ManjunathOfficer | Stock Award(Grant) at price 132.35 per share. | 2.5K | $337.49K |
| Aug 20, 2026 | Betz MichaelOfficer | Stock Award(Grant) at price 132.35 per share. | 12.4K | $1.65M |
| Aug 10, 2026 | Beard Stephen W.Chief Executive Officer | Sale at price 130.34 per share. | 3.5K | $462.07K |
| Aug 6, 2026 | Beck Douglas GGeneral Counsel | Sale at price 135.81 per share. | 4.5K | $614.68K |
| Aug 6, 2026 | Phelan, Robert JohnChief Financial Officer | Sale at price 135.15 per share. | 2.2K | $295.44K |
| Jul 12, 2026 | Beard Stephen W.Chief Executive Officer | Sale at price 132.75 per share. | 5.3K | $702.40K |
| Jul 7, 2026 | Beck Douglas GGeneral Counsel | Sale at price 135.34 - 135.40 per share. | 5.1K | $688.91K |
| Jul 7, 2026 | Phelan, Robert JohnChief Financial Officer | Sale at price 135.39 - 135.41 per share. | 5.3K | $719.50K |
| Jun 10, 2026 | Beard Stephen W.Chief Executive Officer | Sale at price 130.14 - 130.78 per share. | 5.3K | $690.20K |
| May 7, 2026 | Beard Stephen W.Chief Executive Officer | Sale at price 131.25 per share. | 15.9K | $2.08M |
| May 7, 2026 | Beck Douglas GOfficer | Sale at price 127.03 per share. | 9.6K | $1.22M |
| May 7, 2026 | Cox Karen SueOfficer | Sale at price 124.50 per share. | 2K | $249.00K |
| May 7, 2026 | Phelan, Robert JohnChief Financial Officer | Sale at price 126.21 per share. | 10K | $1.26M |
| Mar 10, 2026 | Malafronte Michael WDirector | Purchase at price 100.86 - 100.94 per share. | 36K | $3.64M |
| Mar 2, 2026 | Malafronte Michael WDirector | Purchase at price 97.97 per share. | 1.2K | $117.56K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.1 | -5.4 | 17.6 | -0.0 | 2.2 | 5.8 | 0.2 | 6.0 | -7.7 | 5.5 | +24.5% | ||
| 2025 | 17.9 | -4.5 | -1.6 | 5.5 | 24.3 | -3.6 | -10.2 | 14.6 | 17.9 | -36.5 | -5.6 | 11.8 | +13.9% |
| 2024 | -14.4 | -1.9 | 3.8 | -3.5 | 29.8 | 5.9 | 15.0 | -3.4 | -0.3 | 7.2 | 13.0 | -0.6 | +54.1% |
| 2023 | 7.5 | 2.5 | -1.3 | 5.0 | 2.3 | -17.3 | 25.9 | 1.4 | -2.3 | 20.9 | 10.0 | 3.5 | +66.1% |
| 2022 | -0.5 | -29.4 | 43.0 | -1.3 | 11.3 | 10.3 | 11.5 | -6.0 | -3.3 | 14.4 | -0.2 | -14.7 | +20.1% |
| 2021 | 13.7 | 1.8 | 0.6 | -13.2 | 6.0 | -2.0 | 2.0 | 1.8 | 2.2 | -2.3 | -19.7 | -0.4 | −12.9% |
| 2020 | -1.3 | -10.5 | -13.2 | 18.6 | 5.3 | -6.9 | 10.2 | -3.3 | -26.1 | -4.5 | 22.1 | 18.6 | −2.9% |
| 2019 | 3.3 | -1.4 | -3.9 | 6.5 | -10.9 | 2.5 | 5.1 | -9.8 | -10.8 | -21.8 | 13.3 | 3.7 | −26.1% |
| 2018 | 9.4 | 0.1 | 3.3 | 0.1 | 0.3 | 0.7 | 13.4 | -12.3 | 0.7 | 5.0 | 14.0 | -18.0 | +12.5% |
| 2017 | 7.4 | -4.0 | 10.3 | 6.8 | -1.2 | 1.5 | -14.4 | 5.2 | 4.8 | 3.1 | 12.2 | 1.4 | +34.8% |
| 2016 | -21.4 | -8.2 | -5.4 | 0.5 | 4.3 | -1.4 | 24.8 | 3.5 | 0.1 | -1.6 | 31.5 | 4.5 | +23.3% |
| 2015 | -10.7 | -13.8 | -8.7 | -9.4 | 5.2 | -5.8 | 1.3 | -13.9 | 4.0 | -13.4 | 0.8 | 6.6 | −46.7% |
| 2014 | 1.8 | 16.2 | 0.9 | 6.2 | -6.2 | 0.3 | -5.6 | 7.4 | -0.3 | 13.1 | 0.9 | -2.8 | +33.7% |
| 2013 | 6.1 | 19.1 | 5.9 | -11.8 | 11.5 | -0.7 | -3.0 | -0.2 | 1.8 | 17.5 | -1.0 | -0.1 | +49.6% |
| 2012 | -1.8 | -5.9 | -4.7 | -5.1 | -15.0 | 13.3 | -36.6 | -1.6 | 17.9 | 15.4 | -0.7 | -9.0 | −38.3% |
| 2011 | 8.6 | 4.1 | 1.5 | -3.9 | 1.8 | 9.8 | 5.1 | -28.9 | -16.3 | 1.9 | -8.4 | 11.4 | −19.8% |
| 2010 | 7.6 | 3.4 | 3.2 | -4.3 | -7.9 | -8.7 | 2.5 | -29.2 | 29.1 | -2.7 | -10.3 | 11.7 | −15.4% |
| 2009 | -6.7 | -3.0 | -7.3 | -11.7 | 2.4 | 14.8 | -0.6 | 2.7 | 8.3 | -0.1 | -1.8 | 4.4 | −1.2% |
| 2008 | 6.2 | -20.4 | -4.8 | 36.2 | 0.1 | -6.0 | 5.9 | -9.2 | -4.0 | 14.4 | 1.4 | -0.1 | +10.5% |
| 2007 | 0.6 | -1.8 | 6.2 | 12.4 | 1.8 | 1.3 | -4.8 | 6.6 | 7.2 | 47.8 | 0.5 | -5.5 | +85.6% |
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Buy / hold / sell counts